LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings376 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
??MICROSTRATEGY INCDelisted
Bond
274.6M$764.9M4.7%
Increased
60
??COINBASE GLOBAL INCDelisted
Bond
384.2M$503M3.1%
Increased
65
??TRIP COM GROUP LTDDelisted
Bond
362.6M$402.4M2.5%
New
81
362.1M$378.4M2.3%
Decreased
0
??LI AUTO INCDelisted
Bond
271.7M$323M2.0%
Increased
52
324.3M$322.6M2.0%
Increased
68
??TRANSMEDICS GROUP INCDelisted
Bond
181.4M$291.1M1.8%
Increased
50
278.2M$290.4M1.8%
Increased
51
??LUMENTUM HLDGS INCDelisted
Bond
242.8M$251.3M1.5%
Increased
48
93.3M$238.2M1.5%
Increased
48
??DRAFTKINGS INC NEWDelisted
Bond
243.9M$218.9M1.3%
Decreased
0
118M$216.5M1.3%
New
70
??MKS INC.Delisted
Bond
217.1M$214.7M1.3%
New
70
??STRATEGY INCDelisted
Bond
99M$212.6M1.3%
New
70
284.5M$208.8M1.3%
Increased
75
156.3M$200.3M1.2%
Decreased
0
??ASCENDIS PHARMA ADelisted
Bond
154.7M$193.9M1.2%
Decreased
0
??FIVE9 INCDelisted
Bond
221.4M$193.8M1.2%
Decreased
0
??SEMTECH CORPDelisted
Bond
133.7M$191.7M1.2%
Increased
51
??CYTOKINETICS INCDelisted
Bond
175.7M$186.7M1.1%
Increased
48
$16.3B
AUM
376
Positions
Q2 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
+0%Q2'23$9.5B+2%Q3'23$9.7B+8%Q4'23$10.5B+15%Q4'24$12.1B+22%Q1'25$14.7B+10%Q2'25$16.3B
Activity profile
$ moved · Q2'25
New41%Increased18%Decreased15%Exited26%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.0 years
<1Q33%1-4Q33%1-2Y11%2Y+23%

LINDEN ADVISORS LP manages $16.3B across 376 positions as of Q2 2025. Top holdings: MICROSTRATEGY INC (4.7%), COINBASE GLOBAL INC (3.1%), TRIP COM GROUP LTD (2.5%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q2 2025 Summary

Active quarter - 131 new positions, 62 exits, 57 increased. No standout high-conviction moves this quarter. Portfolio: $16.3B across 376 positions.

Top holdings by portfolio weight

Total AUM$16B
MICROSTRATEG4.70%
COINBASE GLO3.09%
TRIP COM GRO2.47%
SUPER MICRO 2.32%
LI AUTO INC1.98%
ZTO EXPRESS 1.98%
TRANSMEDICS 1.79%
LIBERTY MEDI1.78%
LUMENTUM HLD1.54%
<![CDATA[MAK1.46%
Other1.34%

Portfolio allocation by GICS sector

Sectors8
Financial Services51.92%
Unknown22.56%
Technology12.80%
Utilities9.62%
Basic Materials1.43%
Consumer Cyclical1.31%
Communication Services0.19%
Healthcare0.17%

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction30
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q3 2024 Q2 2026+157.4M shares+$200.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used